Buscar
01/07/2026
Mullerian adenosarcoma of the uterus, ovary and peritoneum: Whole transcriptomic digital spatial profiling (DSP) in a cohort of 42 tumors
D'Angelo, E, Kingsley, LG, Espinosa, I, Cipriani, V, Marotta, A, Nasr, S, Zdravkovic, S, Howitt, BE, Prat, J. Mullerian adenosarcoma of the uterus, ovary and peritoneum: Whole transcriptomic digital spatial profiling (DSP) in a cohort of 42 tumors. HUMAN PATHOLOGY. 2026; 173DOI:10.1016/j.humpath.2026.106117. PMID:41932512. IF:2.600(Q2/4D).
01/03/2026
Serous Tubal Intraepithelial Carcinoma (STIC): Incidence and Clinical Implications in 254 Consecutive Cases from a Tertiary Care Hospital
Misad, C, Cajo, SA, Espadaler, I, Muñoz, R, D'Angelo, E, Gallardo, A, Espinosa, I, Prat, J. Serous Tubal Intraepithelial Carcinoma (STIC): Incidence and Clinical Implications in 254 Consecutive Cases from a Tertiary Care Hospital. LABORATORY INVESTIGATION. 2026; 106(3)DOI:10.1016/j.labinv.2025.105314. PMID:. IF:4.200(Q1/1D).
01/02/2026
Cardiac plasmacytoma with extensive infiltration: multimodal diagnosis and therapeutic challenges: a case report
Rodríguez-Fraga, P, Cascos, E, Cuartas, A, Espadaler, I. Cardiac plasmacytoma with extensive infiltration: multimodal diagnosis and therapeutic challenges: a case report. European Heart Journal-Case Reports. 2026; 10(2)DOI:10.1093/ehjcr/ytag102. PMID:41728229. IF:(Q/D).
01/03/2026
ctDNA clearance after induction therapy as predictor of response to radical chemoradiotherapy in locally advanced head and neck cancer
Bruixola, G, Martín-Arana, J, Vidales, Z, Peon, G, Gimeno-Valiente, F, Tous, S, Camblor, DG, Cirauqui, B, García-Bartolomé, M, Sumarroca, A, Martínez-Castedo, B, Leon, X, Micó-García, B, Iglesias-Martínez, B, García-March, A, Segui, V, Pavón, MA, Quirós, B, Clavero, O, Maroñas, M, Escorihuela-Garcia, V, Tarazona, N, Alemany, L, Oliva, M. ctDNA clearance after induction therapy as predictor of response to radical chemoradiotherapy in locally advanced head and neck cancer. RADIOTHERAPY AND ONCOLOGY. 2026; 216DOI:. PMID:. IF:5.300(Q1/2D).
01/06/2026
Artificial Intelligence-Assisted reflectance confocal microscopy for Real-Time intraoperative margin assessment in oral squamous cell carcinoma
Hosseinzadeh, F, Zanoni, D, França, PDD, Valero, C, Peterson, G, Ardigo, M, Ghossein, R, Dusza, SW, Pillarsetty, N, Kose, K, Wong, RJ, Ganly, I, Rajadhyaksha, M, Patel, SG. Artificial Intelligence-Assisted reflectance confocal microscopy for Real-Time intraoperative margin assessment in oral squamous cell carcinoma. ORAL ONCOLOGY. 2026; 177DOI:10.1016/j.oraloncology.2026.107939. PMID:41932031. IF:3.900(Q1/2D).
01/03/2025
Lower lip reconstruction with the Karapandzic flap or the Colmenero flap: Description of results
Sumarroca, A, Vega, C, López, S, Leidinger, A, Pedemonte, G, León, X, Costa-González, JM. Lower lip reconstruction with the Karapandzic flap or the Colmenero flap: Description of results. Acta Otorrinolaringologica Espanola. 2025; 76(2)DOI:10.1016/j.otorri.2024.10.001. PMID:39923991. IF:(Q/D).
01/03/2026
Cochlear implant failures and complications: What should radiologists look for?
Moreno, EG, Pizarro, MPV, Dotu, CO, Martínez, AL, Escalante, JEM, Beltran, JD. Cochlear implant failures and complications: What should radiologists look for?. Radiologia. 2026; 68(2)DOI:10.1016/j.rx.2025.501685. PMID:. IF:(Q/D).
01/04/2026
Final clinical data of a phase 1 dose-escalation study of WVT078, a BCMA×CD3 bispecific antibody, alone and in combination with ?-secretase inhibitor WHG626 in patients with relapsed and/or refractory multiple myeloma
Schjesvold, F, Spencer, A, Cohen, YC, Ocio, EM, Lopez-Pardo, J, Cafro, AM, Callander, NS, Kaufman, JL, Mohan, M, Wermke, M, Doki, N, Kan, RBC, Milanez-Almeida, P, Stein, A, Trabucco, G, Ye, S, Kulec, K, Sechaud, R, Banerjee, S, Zhong, HQ, Lai, CT, Rauch, PJ, Raab, MS. Final clinical data of a phase 1 dose-escalation study of WVT078, a BCMA×CD3 bispecific antibody, alone and in combination with ?-secretase inhibitor WHG626 in patients with relapsed and/or refractory multiple myeloma. CANCER. 2026; 132(7)DOI:10.1002/cncr.70341. PMID:41880322. IF:5.100(Q1/3D).